Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 · New England Journal of Medicine · 2,779 citations
https://doi.org/10.1056/nejmoa1215734
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.2K
Papers
60.4K
Citations
112
h-index
341
i10-index
Gert Van Assche is an academic researcher. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 112, co-authored 1043 publications.
ORCID: 0000-0003-0401-4664https://doi.org/10.1056/nejmoa1215734
https://doi.org/10.1093/ecco-jcc/jjw168
https://doi.org/10.1056/nejmoa020888
https://doi.org/10.1038/ajg.2015.233
https://doi.org/10.1016/s0016-5107(04)01878-4
https://doi.org/10.1053/j.gastro.2011.10.032
Click to start Chat